Understanding How a Key Pathway Controls Protein Production
Molecular Mechanisms of Translation Regulation by the eEF2K Pathway
This research explores how a specific cellular pathway, called eEF2K, manages the creation of proteins, which is important for understanding conditions like autoimmune diseases and cancers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Santa Cruz NIH-funded |
| Lab location | 1 site (Santa Cruz, United States) |
| Project ID | NIH-11145808 on NIH RePORTER |
What this research studies
Our cells constantly make proteins, and a pathway called eEF2K acts like a control center, integrating signals to manage this process. eEF2K specifically targets another factor, eEF2, which then influences how proteins are built. While eEF2K generally slows down protein production, it can also promote the making of certain specific proteins, and we want to understand how this happens. We recently found that active eEF2K can cause ribosomes, the cell's protein factories, to become temporarily inactive by binding with other proteins. By understanding these detailed mechanisms, we hope to shed light on how eEF2K contributes to various human diseases, including neurological issues, infections, cancers, and autoimmune disorders.
Who could benefit from this research
Good fit: This foundational research does not directly involve patient participation at this stage, but aims to benefit those affected by autoimmune diseases, cancers, and cardiovascular diseases in the future.
Not a fit: Patients whose conditions are not related to the eEF2K pathway or protein synthesis regulation may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to target eEF2K for treating a range of diseases, including autoimmune conditions and cancers.
How similar studies have performed: This project builds on recent discoveries by the research team but aims to uncover entirely new mechanisms of how eEF2K regulates protein production.
Where this research is happening
Santa Cruz, United States
- University of California Santa Cruz — Santa Cruz, United States (Active)
Researchers
- Principal investigator: Loerch, Sarah — University of California Santa Cruz
- Study coordinator: Loerch, Sarah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.